Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
XTNT

XTNT - Xtant Medical Holdings Inc Stock Price, Fair Value and News

$0.62+0.01 (+1.64%)
Market Closed

66/100

XTNT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

66/100

XTNT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.78

Target 3M

$0.68

Target 6M

$0.71

XTNT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XTNT Price Action

Last 7 days

-1.6%

Last 30 days

-21.5%

Last 90 days

-32.6%

Trailing 12 Months

10.7%

XTNT RSI Chart

XTNT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XTNT Valuation

Market Cap

86.8M

Price/Earnings (Trailing)

49.56

Price/Sales (Trailing)

0.65

EV/EBITDA

13.77

Price/Free Cashflow

16.78

XTNT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.78

Target 3M

$0.68

Target 6M

$0.71

XTNT Fundamentals

XTNT Revenue

Revenue (TTM)

133.1M

Rev. Growth (Yr)

19.04%

Rev. Growth (Qtr)

-6.09%

XTNT Earnings

Earnings (TTM)

1.8M

Earnings Growth (Yr)

126.04%

Earnings Growth (Qtr)

-63.15%

XTNT Profitability

EBT Margin

1.70%

Return on Equity

3.48%

Return on Assets

1.65%

Free Cashflow Yield

5.96%

XTNT Investor Care

Shares Dilution (1Y)

0.72%

Diluted EPS (TTM)

0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025122.3M127.8M133.1M0
2024101.2M110.9M113.9M117.3M
202363.0M67.9M78.5M91.3M
202255.7M56.0M56.7M58.0M
202151.1M55.5M55.3M55.3M
202062.7M58.0M56.3M53.3M
201971.0M67.5M66.0M64.7M
201878.5M75.8M73.3M72.2M
201791.1M91.1M87.8M82.6M
201670.8M82.4M87.8M90.0M
201535.9M36.9M46.2M59.3M
201433.4M34.0M34.5M35.3M
201333.8M33.9M32.9M33.1M
201231.9M32.6M34.0M33.0M
201119.1M22.8M26.5M30.1M
201000015.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Xtant Medical Holdings Inc

XTNT
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
 CEO
 WEBSITExtantmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES134

Xtant Medical Holdings Inc Frequently Asked Questions

XTNT is the stock ticker symbol of Xtant Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Xtant Medical Holdings Inc is 86.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check XTNT's fair value in chart for subscribers.

The fair value guage provides a quick view whether XTNT is over valued or under valued. Whether Xtant Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Xtant Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XTNT.

As of Wed Jan 28 2026, XTNT's PE ratio (Price to Earnings) is 49.56 and Price to Sales (PS) ratio is 0.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XTNT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Xtant Medical Holdings Inc has provided -0.316 (multiply by 100 for percentage) rate of return.